Showing 60,041 - 60,060 results of 112,403 for search '(( 5 ((ppm decrease) OR (a decrease)) ) OR ( a ((fold decrease) OR (point decrease)) ))', query time: 1.77s Refine Results
  1. 60041

    <i>In vitro</i> 6xHis-CBU0823 activity assays for ME (A), LDH (B) and MDH (C) function, including the influence of varied pH (D), and substituted cofactors (E and F). by Janine Hofmann (11273418)

    Published 2021
    “…<p>(A) ME activity was observed for 20 μg 6xHis-CBU0823 in the ME standard assay containing 3 mM malate, 5 mM NAD<sup>+</sup>, 1 mM MnCl<sub>2</sub>. 28.8 μg 6xHis-oMLE and 6xHis-mock purification negative control had no activity. …”
  2. 60042

    SGS-LTER Impact of Labile and Recalcitrant Carbon Treatments on Plant Communities (Density) in a Semiarid Ecosystem on the Central Plains Experimental Range, Nunn, Colorado, USA 19... by Ingrid Burke (10059655)

    Published 2023
    “…In a 10-year study, we assessed the influence of five carbon (C) treatments on the labile C and nitrogen (N) pools of historically N enriched plots on the Shortgrass Steppe Long Term Ecological Research site located in northeastern Colorado. …”
  3. 60043

    S1 Data - by Yukai Luo (14172429)

    Published 2025
    “…The findings from the 16S rDNA assay indicate that UC-MSCs treatment effectively lower α-diversity induced such as Chao 1 and ACE, as well as β-diversity, leading to a decrease in microbiota abundance. The findings from the metabolomics analysis revealed that the metabolites exhibiting notable variances were primarily composed of Lipids and lipid-like molecules, Organoheterocyclic compounds, Organic acids and derivatives, and Benzenoids, indicating the potential of UC-MSCs to exert antifibrotic effects via these metabolic pathways.…”
  4. 60044
  5. 60045
  6. 60046

    Data_Sheet_1_Trends of late HIV presentation and advance HIV disease among newly diagnosed HIV cases in Jiangsu, China: A serial cross-sectional study from 2008 to 2020.docx by Lingen Shi (11246098)

    Published 2022
    “…Patients infected via heterosexual transmission had a higher risk of being classified as AHD (aOR: 1.13, 95%CI: 1.06–1.21) than patients infected via homosexual transmission. …”
  7. 60047
  8. 60048
  9. 60049
  10. 60050
  11. 60051
  12. 60052

    DataSheet1_Does Change in Physical Activity During the Initial Phase of the COVID-19 Pandemic Predict Psychological Symptoms in Physically Active Adults? A Six-Month Longitudinal S... by Audun Havnen (12836642)

    Published 2022
    “…<p>Objectives: The current study aimed to investigate if change in physical activity during the initial phase of the COVID-19 pandemic predicted severity of anxiety and depression symptoms 6 months later in physically active adults.</p><p>Methods: A total of 855 respondents (32.6% women) completed the Hospital Anxiety and Depression Scale (HADS) at two time points and reported change in physical activity habits in the first 3 months of the COVID-19 lockdown in Norway.…”
  13. 60053

    Presentation_1_Detection of Urinary Exosomal HSD11B2 mRNA Expression: A Useful Novel Tool for the Diagnostic Approach of Dysfunctional 11β-HSD2-Related Hypertension.pptx by Domenica De Santis (10044554)

    Published 2021
    “…In the AME family, HSD11B2 copy number correlated with both F/E and THF+5αTHF/THE ratios, whereas in EH patients, a high F/E ratio reflected a reduced HSD11B2 mRNA expression.…”
  14. 60054
  15. 60055
  16. 60056

    DataSheet_1_B Cell Subsets as Severity-Associated Signatures in COVID-19 Patients.pdf by Víctor A. Sosa-Hernández (9722861)

    Published 2020
    “…Background<p>SARS-CoV-2 infection represents a global health problem that has affected millions of people. …”
  17. 60057

    Data Sheet 1_CD56neg CD16+ cells represent a distinct mature NK cell subset with altered phenotype and are associated with adverse clinical outcome upon expansion in AML.pdf by Julia Wlosik (20539100)

    Published 2025
    “…Here, we validated our findings in a validation cohort of N=38 AML patients. AML patients with CD56neg CD16+ NK cells expansion at diagnosis had decreased overall survival (HR[CI95]=5.5[1.2-24.5], p=0.0251) and relapse-free survival (HR[CI95]=13.1[1.9-87.5], p=0.0079) compared to AML patients without expansion after 36 months follow-up. …”
  18. 60058

    Data Sheet 2_CD56neg CD16+ cells represent a distinct mature NK cell subset with altered phenotype and are associated with adverse clinical outcome upon expansion in AML.pdf by Julia Wlosik (20539100)

    Published 2025
    “…Here, we validated our findings in a validation cohort of N=38 AML patients. AML patients with CD56neg CD16+ NK cells expansion at diagnosis had decreased overall survival (HR[CI95]=5.5[1.2-24.5], p=0.0251) and relapse-free survival (HR[CI95]=13.1[1.9-87.5], p=0.0079) compared to AML patients without expansion after 36 months follow-up. …”
  19. 60059
  20. 60060